4//SEC Filing
Kirk Christopher J. 4
Accession 0001209191-23-043195
CIK 0001645666other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 4:20 PM ET
Size
7.1 KB
Accession
0001209191-23-043195
Insider Transaction Report
Form 4
Kirk Christopher J.
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2023-07-20$0.90/sh+48,950$44,055→ 431,348 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-07-20−48,950→ 74,411 totalExercise: $0.90Exp: 2025-09-09→ Common Stock (48,950 underlying)
Footnotes (2)
- [F1]Total reflects 914 shares of common stock acquired on November 15, 2022 through the Company's 2018 Employee Stock Purchase Plan.
- [F2]Fully vested and exercisable.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001744253
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 4:20 PM ET
- Size
- 7.1 KB